Literature DB >> 1123548

A micro-technique for detection of leukocyte agglutinins.

A F Jiang, P Lalezari.   

Abstract

Mesh:

Substances:

Year:  1975        PMID: 1123548     DOI: 10.1016/0022-1759(75)90135-0

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


× No keyword cloud information.
  5 in total

1.  Drug-induced neutropenia associated with anti-neutrophil cytoplasmic antibodies (ANCA): possible involvement of complement in granulocyte cytotoxicity.

Authors:  T Akamizu; S Ozaki; H Hiratani; H Uesugi; J Sobajima; Y Hataya; N Kanamoto; M Saijo; Y Hattori; K Moriyama; K Ohmori; K Nakao
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

2.  Anti-SSB/La is one of the antineutrophil autoantibodies responsible for neutropenia and functional impairment of polymorphonuclear neutrophils in patients with systemic lupus erythematosus.

Authors:  S-C Hsieh; H-S Yu; W-W Lin; K-H Sun; C-Y Tsai; D-F Huang; Y-Y Tsai; C-L Yu
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

3.  Antibodies against human neutrophil antigens in non-transfused women with red blood cell alloimmunisation induced by pregnancy.

Authors:  Juliana Oliveira Martins; Elyse Moritz; Samira A Abbas; Larissa B Lopes; Melca M O Barros; Akemi K Chiba; Dante M Langhi; José O Bordin
Journal:  Blood Transfus       Date:  2020-10-14       Impact factor: 3.443

4.  Immunological and haematological changes during high-dose immunoglobulin therapy in an infant with autoimmune neutropenia.

Authors:  H Ikeda; T Ozawa; H Takahashi; M Eguchi; T Furukawa; A Okuyama; K Saito; S Furusawa
Journal:  Eur J Pediatr       Date:  1987-07       Impact factor: 3.183

5.  Leukocyte-Reactive Antibodies in Female Blood Donors: The Austrian Experience.

Authors:  Marlies Schönbacher; Nicole Aichinger; Lisa Weidner; Christof Jungbauer; Christoph Grabmer; Beate Schuha; Eva Rohde; Wolfgang Mayr; Günther Körmöczi
Journal:  Transfus Med Hemother       Date:  2020-09-23       Impact factor: 3.747

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.